India Globalization Capital Inc., of Bethesda, Md., reported in vitro data compiled from genetically engineered cell lines showing that, at varying concentrations of tetrahydrocannabinol (THC), the production of amyloid beta 40 protein decreases by as much as 50 percent over a 48-hour period.